Ozempic Prescribing Information, Novo Nordisk (2023) Medications containing semaglutide marketed for Type 2 diabetes or weight loss, FDA (2023) How to use the Ozempic pen, Novo Nordisk (2023) Possible side effects of Ozempic (semaglutide) injection, Novo Nordisk (2023) As Ozempics Popularity Soars, Heres What to Know About Semaglutide and Weight Loss, JAMA (2023) Medication Storage Appropriateness in US Households, Innovations in Pharmacy (2021) Public Interest in the Off-Label Use of Glucagon-Like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis, Aesthetic Surgery Journal (2023) Frequently asked questions about Wegovy, NovoMEDLINK (2023) Wegovy prescribing information, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

CONCLUSION Although more research and consensus are needed to determine the optimal length of time for holding GLP-1 receptor agonists before a procedure requiring anesthesia, it is important for practitioners and patients to be aware of the increased risks for aspiration and to consider strategies to mitigate harm
Caution is also warranted when dismissing smaller quantitative sex differences in the therapeutic or adverse effect outcomes, especially considering the staggeringly large numbers of patients taking GLP-1-based therapeutics
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes